Myriad Genetics MYGN West Salt Lake City — Operating lease, liability
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
The Company previously amended the lease for its west Salt Lake City headquarters in 2024 to expand the facility in anticipation of future operating needs. During the three months ended March 31, 2026, the Company took possession of the remaining square footage of the west Salt Lake City facility and recognized an additional $2.7 million right-of-use asset and corresponding lease liability, net of tenant improvement allowance not yet received of approximately $6.5 million. Future rent payments associated with the expanded space are approximately $18.2 million.
Item 1. Financial Statements.
FAQ
- What is Myriad Genetics's west salt lake city — operating lease, liability?
- Myriad Genetics (MYGN) reported west salt lake city — operating lease, liability of $2.7M in Q1 2026.
- What does west salt lake city — operating lease, liability mean?
- Represents the present value of future lease payments for operating facilities located in the West Salt Lake City region. This metric reflects the company's long-term financial obligation for leased real estate assets used in diagnostic operations. Monitoring this liability is essential for assessing the company's fixed-cost structure and long-term solvency.
Ask your AI about Myriad Genetics's west salt lake city — operating lease, liability.
Connect your AI assistant and compare it to peers, right in your chat.
